Who owns SOPHiA GENETICS SA (SOPH)? Elite investor 13F holders
2 tracked elite investors reported holding SOPHiA GENETICS SA as of 2026-06-30, including Akre Capital Management, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Industrials · Commercial & Professional Services
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Akre Capital Management | SOPHIA GENETICS SA | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 21459438.00 USD | 3719140.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | SOPHIA GENETICS SA | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 653741.00 USD | 113300.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.